{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:52:28Z","timestamp":1787997148329,"version":"build-2784847793"},"reference-count":73,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2010\u20130029460"],"award-info":[{"award-number":["2010\u20130029460"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jns.2011.03.023","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T10:52:18Z","timestamp":1302864738000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Increased plasma levels of lipocalin 2 in mild cognitive impairment"],"prefix":"10.1016","volume":"305","author":[{"given":"Jihye","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungho","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2011.03.023_bb0005","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(03)00124-6","article-title":"Inflammatory processes in Alzheimer's disease","volume":"27","author":"McGeer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jns.2011.03.023_bb0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awh451","article-title":"The 9year cognitive decline before dementia of the Alzheimer type: a prospective population-based study","volume":"128","author":"Amieva","year":"2005","journal-title":"Brain"},{"issue":"Suppl","key":"10.1016\/j.jns.2011.03.023_bb0015","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/nrn1433","article-title":"Advances in the early detection of Alzheimer's disease","volume":"10","author":"Nestor","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2011.03.023_bb0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1037\/0894-4105.19.4.520","article-title":"Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis","volume":"19","author":"Backman","year":"2005","journal-title":"Neuropsychology"},{"key":"10.1016\/j.jns.2011.03.023_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S1041610207005509","article-title":"High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients","volume":"20","author":"Schmidtke","year":"2008","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jns.2011.03.023_bb0035","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(86)90002-3","article-title":"Cholinergic function and intellectual decline in Alzheimer's disease","volume":"19","author":"Collerton","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2011.03.023_bb0045","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.jns.2011.03.023_bb0050","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","article-title":"Cholinergic markers in elderly patients with early signs of Alzheimer disease","volume":"281","author":"Davis","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2011.03.023_bb0055","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jns.2011.03.023_bb0060","first-page":"21","article-title":"Evidence of neuronal oxidative damage in Alzheimer's disease","volume":"149","author":"Good","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jns.2011.03.023_bb0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease","volume":"3","author":"LaFerla","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jns.2011.03.023_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0079-6123(06)61021-2","article-title":"Traumatic brain injury and Alzheimer's disease: a review","volume":"161","author":"Van Den Heuvel","year":"2007","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.jns.2011.03.023_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jns.2011.03.023_bb0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0197-4580(01)00289-5","article-title":"Inflammation, autotoxicity and Alzheimer disease","volume":"22","author":"McGeer","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2011.03.023_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.exger.2006.09.015","article-title":"Increased production of inflammatory cytokines in mild cognitive impairment","volume":"42","author":"Magaki","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jns.2011.03.023_bb0090","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","article-title":"The metabolic syndrome, inflammation, and risk of cognitive decline","volume":"292","author":"Yaffe","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2011.03.023_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000245156","article-title":"Peripheral cytokines and chemokines in Alzheimer's disease","volume":"28","author":"Lee","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jns.2011.03.023_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2011.03.023_bb0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1755-5949.2009.00104.x","article-title":"Biological marker candidates of Alzheimer's disease in blood, plasma, and serum","volume":"15","author":"Schneider","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jns.2011.03.023_bb0110","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.neurobiolaging.2007.08.010","article-title":"Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment","volume":"30","author":"Brys","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2011.03.023_bb0115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2004.01368.x","article-title":"CSF biomarkers for mild cognitive impairment","volume":"256","author":"Blennow","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.jns.2011.03.023_bb0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","article-title":"Cerebrospinal fluid protein biomarkers for Alzheimer's disease","volume":"1","author":"Blennow","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.jns.2011.03.023_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clineuro.2004.10.011","article-title":"CSF biomarkers for mild cognitive impairment and early Alzheimer's disease","volume":"107","author":"Andreasen","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jns.2011.03.023_bb0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1196\/annals.1379.012","article-title":"Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease","volume":"1097","author":"de Leon","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jns.2011.03.023_bb0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0140","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","article-title":"Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase","volume":"268","author":"Kjeldsen","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2011.03.023_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10534-005-3251-7","article-title":"Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein","volume":"19","author":"Borregaard","year":"2006","journal-title":"Biometals"},{"issue":"Pt 1","key":"10.1016\/j.jns.2011.03.023_bb0150","first-page":"1","article-title":"The lipocalin protein family: structure and function","volume":"318","author":"Flower","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.jns.2011.03.023_bb0155","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.jns.2011.03.023_bb0160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.WCB.0000123141.67811.91","article-title":"Translation-state analysis of gene expression in mouse brain after focal ischemia","volume":"24","author":"MacManus","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jns.2011.03.023_bb0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1749-6632.2003.tb03213.x","article-title":"Tissue involution and the acute phase response","volume":"995","author":"Nilsen-Hamilton","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jns.2011.03.023_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2009.05.027","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene","volume":"288","author":"Bolignano","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jns.2011.03.023_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/geno.1997.4896","article-title":"Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans","volume":"45","author":"Cowland","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.jns.2011.03.023_bb0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1003708808934","article-title":"Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression","volume":"31","author":"Friedl","year":"1999","journal-title":"Histochem J"},{"key":"10.1016\/j.jns.2011.03.023_bb0185","doi-asserted-by":"crossref","first-page":"24438","DOI":"10.1074\/jbc.M211980200","article-title":"Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome","volume":"278","author":"Lafon-Cazal","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2011.03.023_bb0190","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1074\/mcp.M500040-MCP200","article-title":"Difference in mass analysis using labeled lysines (DIMAL-K): a new, efficient proteomic quantification method applied to the analysis of astrocytic secretomes","volume":"4","author":"Delcourt","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jns.2011.03.023_bb0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.jcbfm.9600557","article-title":"Lipocalin 2 is a choroid plexus acute-phase protein","volume":"28","author":"Marques","year":"2008","journal-title":"J Cerebr Blood F Met"},{"key":"10.1016\/j.jns.2011.03.023_bb0200","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/01.STR.27.10.1734","article-title":"Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases","volume":"27","author":"Elneihoum","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2011.03.023_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2002-37089","article-title":"Adult stroke and perinatal brain damage: like grandparent, like grandchild?","volume":"33","author":"Leviton","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jns.2011.03.023_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.jns.2011.03.023_bb0215","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.03.023_bb0220","first-page":"255","article-title":"Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV \u2014 options book)","volume":"28","author":"Rabe-Jablonska","year":"1994","journal-title":"Psychiatr Pol"},{"key":"10.1016\/j.jns.2011.03.023_bb0225","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jns.2011.03.023_bb0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2009.01.058","article-title":"Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases","volume":"1265","author":"Yin","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2011.03.023_bb0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-0173(99)00007-7","article-title":"Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function","volume":"30","author":"Raivich","year":"1999","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.jns.2011.03.023_bb0240","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1523\/JNEUROSCI.5273-08.2009","article-title":"Lipocalin-2 is an autocrine mediator of reactive astrocytosis","volume":"29","author":"Lee","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2011.03.023_bb0245","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.179.5.3231","article-title":"A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia","volume":"179","author":"Lee","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2011.03.023_bb0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2011.03.023_bb0255","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer's disease","volume":"74","author":"Tarkowski","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2011.03.023_bb0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/exnr.2001.7814","article-title":"Cerebrospinal fluid amyloid beta(1\u201342) levels in the mild cognitive impairment stage of Alzheimer's disease","volume":"172","author":"Maruyama","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0265","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.neurobiolaging.2005.10.007","article-title":"Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease","volume":"27","author":"Galimberti","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2011.03.023_bb0270","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neulet.2008.03.019","article-title":"Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease","volume":"436","author":"Kim","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2011.03.023_bb0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.imlet.2008.02.002","article-title":"Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease","volume":"117","author":"Bermejo","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jns.2011.03.023_bb0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0891988709351832","article-title":"Decreased C-reactive protein levels in Alzheimer disease","volume":"23","author":"O'Bryant","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0285","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000083497","article-title":"Diminished production of proinflammatory cytokines in patients with Alzheimer's disease","volume":"19","author":"Richartz","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jns.2011.03.023_bb0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.exger.2004.12.003","article-title":"Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients","volume":"40","author":"Reale","year":"2005","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jns.2011.03.023_bb0295","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0531-5565(98)00013-8","article-title":"The importance of inflammatory mechanisms in Alzheimer disease","volume":"33","author":"McGeer","year":"1998","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jns.2011.03.023_bb0300","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/glia.20207","article-title":"Astrocyte activation and reactive gliosis","volume":"50","author":"Pekny","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.jns.2011.03.023_bb0305","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4522(02)00359-7","article-title":"Chemically induced neuronal damage and gliosis: enhanced expression of the proinflammatory chemokine, monocyte chemoattractant protein (MCP)-1, without a corresponding increase in proinflammatory cytokines(1)","volume":"115","author":"Little","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2011.03.023_bb0310","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.bjc.6604329","article-title":"Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia","volume":"98","author":"Moniaux","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jns.2011.03.023_bb0315","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1369\/jhc.2009.953257","article-title":"Lipocalin2 Expressions correlate significantly with tumor differentiation in epithelial ovarian cancer","volume":"57","author":"Cho","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jns.2011.03.023_bb0320","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/ijc.22352","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition","volume":"120","author":"Lim","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jns.2011.03.023_bb0325","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","article-title":"Mild cognitive impairment: ten years later","volume":"66","author":"Petersen","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archneur.63.5.665","article-title":"Neuropathologic features of amnestic mild cognitive impairment","volume":"63","author":"Petersen","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0335","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3233\/JAD-2009-1022","article-title":"Adiposity, type 2 diabetes, and Alzheimer's disease","volume":"16","author":"Luchsinger","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jns.2011.03.023_bb0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000017209","article-title":"Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype","volume":"11","author":"Licastro","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jns.2011.03.023_bb0345","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1212\/01.WNL.0000073620.42047.D7","article-title":"Inflammatory markers and cognition in well-functioning African-American and white elders","volume":"61","author":"Yaffe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.03.023_bb0350","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/01.WNL.0000158281.08946.68","article-title":"Serum inflammatory proteins and cognitive decline in older persons","volume":"64","author":"Dik","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.03.023_bb0355","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archneur.63.4.538","article-title":"Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease","volume":"63","author":"Galimberti","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0360","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.10531","article-title":"Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients","volume":"53","author":"Galimberti","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.03.023_bb0365","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9","article-title":"Cerebrospinal fluid A beta 42 is increased early in sporadic Alzheimer's disease and declines with disease progression","volume":"45","author":"Jensen","year":"1999","journal-title":"Ann Neurol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1100133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1100133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:40:33Z","timestamp":1758382833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1100133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":73,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0022510X1100133X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2011.03.023","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased plasma levels of lipocalin 2 in mild cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2011.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}